Fiscal Year 2021 Budget
CDC’s National Center on Birth Defects and Developmental Disabilities (NCBDDD) fiscal year (FY) 2021 appropriation includes $167,810,000 for Child Health and Development, Health and Development with Disabilities, and Public Health Approach to Blood Disorders.
Funds are currently supporting surveillance, research, and prevention activities that address issues with the greatest public health burden and implementing strategies to improve health outcomes.
|
NCBDDD FY 2021 Appropriations (in thousands) |
|
|---|---|
| Birth Defects | $19,000 |
| Fetal Death | $900 |
| Fetal Alcohol Syndrome | $11,000 |
| Folic Acid | $3,150 |
| Infant Health | $8,650 |
| Autism | $23,100 |
| Neonatal Abstinence Syndrome | $2,250 |
| Surveillance for Emerging Threats to Moms and Babies | $10,000 |
| Disability and Health | $36,000 |
| Tourette Syndrome | $2,000 |
| Early Hearing Detection and Intervention (EHDI) | $10,760 |
| Muscular Dystrophy | $6,000 |
| Attention Deficit Hyperactivity Disorder (ADHD) | $1,900 |
| Fragile X | $2,000 |
| Spina Bifida | $7,000 |
| Congenital Heart Failure | $7,000 |
| Public Health Approach to Blood Disorders | $4,400 |
| Hemophilia CDC Activities | $3,500 |
| Thalassemia | $2,100 |
| Hemophilia Treatment Centers | $5,100 |
| Sickle Cell Research | $2,000 |
| NCBDDD Total | $167,810 |
| COVID-19 Response* | $1,074 |
Note: NCBDDD spent $4,831 of its annual appropriations on COVID related activities for people with the conditions we serve.
*NCBDDD received an additional $1,074 beyond NCBDDD appropriations to support additional COVID related activities.
Page last reviewed: January 12, 2022